Clinical Trial Update: Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating post-operative adjuvant therapy with or without GammaTile plus systemic therapy for glioblastoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• GammaTile

Snippet

Sponsor: GT Medical Technologies, Inc. | Conditions: Glioblastoma | Phase 4 | Status: WITHDRAWN